Company / Return on Assets (ROA)
Moderna Return on Assets (ROA) History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-22.9%
FY2025
5-year range
-25.6% / -2.1%
FY2021-FY2025
Trend
+9.2%
vs FY2024
Sector context
#106 of 213
Health Care
What the data says
At -22.9%, Moderna's return on assets (roa) ranks #106 of 213 in the Health Care sector. Return on Assets (ROA) has fluctuated over the past 9 years, ranging from -32.3% in FY2019 to -2.1% in FY2021.
Based on SEC 10-K filings.
-22.9% in FY2025 with a 5-year CAGR of -12.7%.
Improved from -25.6% to -22.9% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -20.0pp
- 5-Year Change
- -12.7pp
- 10-Year Change
- -
Sector benchmark
#106 of 213 in Health CareTop 50% of 213This company -22.9% Sector average -24.1%
▼
+5.3% above sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 9.2% year-over-year.
- Currently 1.3pp above the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2021.
- Lowest return on assets (roa) in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -22.9% | +9.2% |
| FY2024 | -25.2% | +1.6% |
| FY2023 | -25.6% | -785.1% |
| FY2022 | -2.9% | -38.9% |
| FY2021 | -2.1% | +79.6% |
| FY2020 | -10.2% | +68.5% |
| FY2019 | -32.3% | -64.9% |
| FY2018 | -19.6% | +16.9% |
| FY2017 | -23.6% | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026